Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering...
Viridian Therapeutics’ $97.7 Million Shares Offering
Cue Health Inc.’s $235 Million Private Financing Round
Wilmer Cutler Pickering Hale and Dorr advised Cue Health Inc. on the deal. Cue Health Inc., a health technology company, announced the closing of its $235...